Somatic Molecular Genetics of Prostate Cancer

作者: Laure Humbert , Mario Chevrette

DOI: 10.1007/978-1-4419-0449-2_5

关键词: Androgen receptorProstate Stem Cell AntigenCancer developmentSomatic cellOncologyMedicineInternal medicineProstateAntigenMolecular geneticsProstate cancer

摘要: Despite progress in diagnosis and treatment, prostate cancer is still one of the most frequent lethal diseases men Western countries. Today, an increasing number cancers are detected through elevated serum prostate-specific antigen (PSA) levels. PSA detection very sensitive. Determining free versus total level has enabled achievement better specificity (Balk et al. 2003), however, this tool remains imperfect. Many patients undergo unnecessary diagnostic procedures, experiencing physiological psychological stress. Similarly, current techniques such as imaging biopsies not optimal thus, hopes high for discovery new molecular markers cancer. Studying progression may reveal insights into mechanisms development to help improve prevention, provide tools diagnosis, well prognosis treatment.

参考文章(233)
Angelo M. De Marzo, Alan K. Meeker, Jonathan I. Epstein, Donald S. Coffey, Prostate Stem Cell Compartments The American Journal of Pathology. ,vol. 153, pp. 911- 919 ,(1998) , 10.1016/S0002-9440(10)65632-5
Bob S. Carter, G. Steven Bova, Terri H. Beaty, Gary D. Steinberg, Barton Childs, William B. Isaacs, Patrick C. Walsh, Hereditary Prostate Cancer: Epidemiologic and Clinical Features Journal of Urology. ,vol. 150, pp. 797- 802 ,(1993) , 10.1016/S0022-5347(17)35617-3
Mahammad S. Shurbaji, Francis P. Kuhajda, Gary R. Pasternack, Thane S. Thurmond, Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator. American Journal of Clinical Pathology. ,vol. 97, pp. 686- 691 ,(1992) , 10.1093/AJCP/97.5.686
Wendy J Langeberg, William B Isaacs, Janet L Stanford, Genetic etiology of hereditary prostate cancer Frontiers in Bioscience. ,vol. 12, pp. 4101- 4110 ,(2007) , 10.2741/2374
Wei Lou, Diane Krill, Rajiv Dhir, Michael J Becich, Jin-Tang Dong, Henry F Frierson Jr, William B Isaacs, John T Isaacs, Allen C Gao, None, Methylation of the CD44 metastasis suppressor gene in human prostate cancer Cancer Research. ,vol. 59, pp. 2329- 2331 ,(1999)
Diha Freije, Paul Cairns, Deborah R. Nusskern, William B. Isaacs, David Sidransky, G. Steven Bova, Hiroyoshi Suzuki, Kenji Okami, Interfocal Heterogeneity of PTEN/MMAC1 Gene Alterations in Multiple Metastatic Prostate Cancer Tissues Cancer Research. ,vol. 58, pp. 204- 209 ,(1998)
Osamu Doi, Masahiko Higashiyama, Cheng-long Huang, Masayuki Miyake, Ken Kodama, Masashi Adachi, Takashi Koh, Yoshiaki Ieki, Toshihiko Taki, Reduced Motility Related protein-1 (MRP-1/CD9) Gene Expression as a Factor of Poor Prognosis in Non-Small Cell Lung Cancer Cancer Research. ,vol. 55, pp. 6040- 6044 ,(1995)
Cheng-Long Huang, Masayuki Miyake, Masashi Adachi, Shin-ichi Itoi, Takashi Koh, Yoshiaki Ieki, Keiji Nakano, Toshihiko Taki, Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Research. ,vol. 55, pp. 4127- 4131 ,(1995)
Ritva Karhu, Jorma J. Isola, Olli-P. Kallioniemi, Anne H. Kallioniemi, Eija R. Hyytinen, Teuvo Tammela, Tapio Visakorpi, Ann-Christine Syvänen, Genetic Changes in Primary and Recurrent Prostate Cancer by Comparative Genomic Hybridization Cancer Research. ,vol. 55, pp. 342- 347 ,(1995)
Antonio Di Cristofano, Marika De Acetis, Andrew Koff, Carlos Cordon-Cardo, Pier P Pandolfi, Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nature Genetics. ,vol. 27, pp. 222- 224 ,(2001) , 10.1038/84879